| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Common Stock | Options Exercise | $47,838 | +1,250 | +12% | $38.27 | 12,040 | 11 Dec 2024 | Direct | F1 |
| transaction | AVNT | Common Stock | Tax liability | $55,232 | -1,121 | -9.3% | $49.27 | 10,919 | 11 Dec 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -1,250 | -100% | $0.000000 | 0 | 11 Dec 2024 | Common Stock | 1,250 | $38.27 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Includes dividend equivalents earned with respect to the vested restricted stock units. |
| F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $38.27 per share and no more than one-third of the grant can vest per year during the first three years. |